Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia

Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia

Background: Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of tumors. Natural killer (NK) cells can play an important role in cancer immune surveillance. The aim of this prospective observational study was to analyze peripheral blood mononuclear cells (PBMCs) in patients with...

Full description

Bibliographic Details
Main Authors: Marta Tenuta, Carla Pandozzi, Francesca Sciarra, Federica Campolo, Alain J. Gelibter, Grazia Sirgiovanni, Enrico Cortesi, Andrea Lenzi, Andrea M. Isidori, Emilia Sbardella, Mary Anna Venneri
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cancers
Subjects:
immune checkpoint inhibitors (ICIs)
natural killer (NK) cells
sarcopenia
peripheral blood mononuclear cells (PBMCs)
lung cancer
non-small-cell lung cancer (NSCLC)
Online Access:https://www.mdpi.com/2072-6694/15/14/3592

Similar Items

Similar Items